` 600587 (Shinva Medical Instrument Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

600587
vs
S
Shanghai Composite

Over the past 12 months, Shinva Medical Instrument Co Ltd has underperformed Shanghai Composite, delivering a return of -6% compared to the Shanghai Composite's +25% growth.

Stocks Performance
600587 vs Shanghai Composite

Loading
600587
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
600587 vs Shanghai Composite

Loading
600587
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
600587 vs Shanghai Composite

Loading
600587
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Shinva Medical Instrument Co Ltd vs Peers

Shanghai Composite
600587
LEG
PMT
DFS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Shinva Medical Instrument Co Ltd
Glance View

Market Cap
9.4B CNY
Industry
Health Care

In the brisk hustle of China's healthcare evolution, Shinva Medical Instrument Co., Ltd. stands as a pivotal player, navigating the intricate world of medical devices and pharmaceutical machinery since its inception in 1943. Rooted deeply in the tangible yet transformative realm of healthcare technology, Shinva has advanced from its initial focus on producing pharmaceutical sterilization equipment to a comprehensive provider of medical solutions. With its headquarters in the tech-driven province of Shandong, Shinva operates in various sectors, providing a multifaceted approach to healthcare. The company’s operations span across diverse segments including medical devices, environmental protection equipment, and pharmaceutical engineering services, ensuring it remains adaptive to contemporary medical demands and regulatory standards. Revenue flows primarily from the design, manufacture, and distribution of medical and laboratory equipment, widening its customer base from local hospitals to international healthcare facilities. Shinva’s portfolio is intriguingly broad, encompassing products that range from high-end sterilization tools and radiation therapy equipment to diagnostic imaging and surgical instruments. This diversification safeguards the company against market volatility while aligning with the ever-increasing demand for efficiency and safety in medical procedures. Moreover, its commitment to research and development underscores its strategic mission to innovate and refine healthcare delivery systems, anchoring its status as a leader in the industry. This adaptability and relentless pursuit of quality enable Shinva to thrive, aptly positioning it to grow alongside China's expansive healthcare sector.

Intrinsic Value
28.16 CNY
Undervaluation 45%
Intrinsic Value
Price
Back to Top